A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02746445|
Recruitment Status : Completed
First Posted : April 21, 2016
Last Update Posted : May 9, 2017
|Condition or disease||Intervention/treatment|
|Autistic Disorder||Other: No intervention|
|Study Type :||Observational|
|Actual Enrollment :||11 participants|
|Official Title:||A Longitudinal Study on the Safety and Efficacy for Subjects With Autism Spectrum Disorder (ASD) Who Received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT)|
|Actual Study Start Date :||April 2016|
|Actual Primary Completion Date :||April 2017|
|Actual Study Completion Date :||April 2017|
No interventions. This is an observation of subjects who received MeRT utilizing assessment documentation.
Other: No intervention
No intervention. This is a longitudinal study looking at subjects who received MeRT treatment.
Other Name: No intervention.
- Change in Childhood Autism Rating Scale (CARS) [ Time Frame: Change from baseline CARS score at 104 weeks post-MeRT treatment ]Symptom reduction in ASD will be measured using the arithmetic reduction in the CARS total score between two time points BL and week 104 (or Early Termination)
- Childhood Autism Rating Scale (CARS) [ Time Frame: Baseline, weeks 5, 10, and 12, and 104 and 156 weeks post-MeRT treatment ]Symptom reduction in ASD will be measured using the arithmetic reduction in the CARS total score between the multiple time points of the MeRT-001 trial (BL, Week 5, 10 and 12), BL, Follow-Up 1 Post-MeRT Treatment (Week 104), and Follow-Up 2 Post-MeRT Treatment (Week 156).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02746445
|United States, California|
|Brain Treatment Center|
|Newport Beach, California, United States, 92660|
|Principal Investigator:||Keun-Young Kim, MD||Brain Treatment Center|